Healthcare / Health Information ServicesTokyo
$566.00
-4.00 (-0.70%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 24%
FCF escenarios
weak_data · normalized FCF $3.6B · quality 55.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$31.4B
P/E
8.9x
↓EV/EBITDA
2.5x
↓ROE
18.5%
↑Gross Margin
74.3%
↑Debt/Equity
0.09
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.1%
FCF CAGR
—
FCF margin
14.4%
FCF / Net income
1.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $29.91B · net income $3.40B · FCF $4.30B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $29.91B | $29.91B | $27.67B | $26.80B | $26.48B |
| Net Income | $3.40B | $3.40B | $2.36B | $753.2M | $-930.5M |
| EBITDA | $6.02B | $6.02B | $5.17B | $2.91B | $1.44B |
| EPS | 61.55 | 61.55 | — | 13.73 | -16.99 |
| Gross Margin | 74.3% | 74.3% | 73.7% | 68.6% | 70.6% |
| Operating Margin | 9.8% | 9.8% | 8.7% | 1.1% | 3.3% |
| Net Margin | 11.4% | 11.4% | 8.5% | 2.8% | -3.5% |
| Balance Sheet | |||||
| Debt/Equity | 0.09 | 0.09 | 0.16 | 0.23 | 0.28 |
| Current Ratio | 3.46 | 3.46 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $4.30B | $4.30B | $2.74B | $3.60B | $-3.59B |
| Returns | |||||
| ROE | 18.5% | 18.5% | 15.3% | 5.4% | -6.6% |
| Valuation | |||||
| P/E | 8.94 | 8.94 | — | 42.97 | — |
| EV/EBITDA | 2.52 | 2.52 | 10.67 | 7.49 | 13.64 |
| P/B | 1.70 | 1.70 | 4.37 | 2.31 | 1.96 |
| Growth & Yield | |||||
| Revenue Growth | 8.1% | 8.1% | 3.2% | 1.2% | — |
| EPS Growth | — | — | — | 180.8% | — |
| Dividend Yield | 3.5% | 3.5% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-6.6%
EPS terminal req.
$50.22
Spread vs growth
14.7%
5Y implied EPS CAGR
-0.3%
EPS terminal req.
$60.77
Spread vs growth
8.4%
10Y implied EPS CAGR
4.7%
EPS terminal req.
$97.87
Spread vs growth
3.4%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.5%
Start / end P/E
n/dx → n/dx
EPS bridge
n/d → 61.55
Residual
-33.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.